New CE Webinars on Respiratory Care
The use of noninvasive ventilation has markedly increased over the past two decades, and noninvasive ventilation has now become an integral tool in the management of both acute and chronic respiratory failure, in both the home setting and in the critical care unit.
Health care is a stressful field that can have an adverse effect on worker well-being. This especially true during the COVID-19 pandemic. Burnout is highly prevalent in healthcare and is associated with adverse outcomes for patients, healthcare workers, and organizations. Burnout is characterized by emotional exhaustion, depersonalization, and lack of professional efficacy. In this presentation, our speaker will define burnout, identify drivers of burnout among healthcare providers, discuss burnout prevalence, and cover strategies to combat burnout.
Noninvasive ventilation (NIV) benefits have become increasingly recognized, in particular, NIV has proven effective for hypercapnic respiratory failure. High-flow nasal cannula (HFNO) has shown promise in treating hypoxic respiratory failure. This presentation will discuss how HFNO with NIV enables a complementary approach for weaning efficiency. In light of the current pandemic, this presentation will also discuss the use of HFNC and NIV therapy in COVID-19 patients. Following the lecture with be an interactive panel discussion with three experts in HFNO and NIV therapies.
The initial fear of COVID-19 transmission to healthcare workers resulted in many choosing to avoid the use of HFNC or NIV therapy in these patients. Most of the concerns were not supported by evidence, rather lack of evidence. This presentation will discuss the use of HFNC and NIV therapy in COVID-19 patients, and present supportive data for its use, while providing suggested parameters important for monitoring success or failure of therapy.
Noninvasive ventilation (NIV) has been successfully used for decades to deliver positive pressure- ventilator support without the need of an artificial airway. Patients with acute and chronic respiratory failure, including those with chronic obstructive pulmonary disease (COPD), have benefitted from noninvasive ventilation. This webinar will focus on the clinical benefits of NIV for COPD patients as they progress through various stages of their care, transitioning from hospital to home. Differences in NIV terminology and technology will be addressed as well as common ventilation concerns in COVID-19 era.
Noninvasive positive pressure ventilation (NPPV) is a proven method of ventilatory support in the treatment of acute respiratory failure without the need of endotracheal intubation thereby reducing its associated morbidity and mortality. Across the continuum of care, specifically the transition from hospital to home, NPPV has played an important role in decreasing readmissions with COPD patients and improving the quality of life. Advanced technology has allowed patients to be managed successfully at home. Based on work at her hospital along with coordination with home care providers, Ms. Lintner will discuss the development of an evidence-based NPPV program that has proven to reduce COPD readmissions, generate significant cost savings and improve the quality of patient care.
Sleep disordered breathing and obstructive sleep apnea (OSA) in particular is recognized as a disorder that afflicts as much as 26% of the population globally. Hospital patients with untreated OSA generate twice the healthcare costs as compared to patients without OSA. Identification of sleep disordered breathing and proper management are important to not only reducing costs, but improving outcomes and managing these disorders over the long term. This webinar provides insights into how these patients can be identified and how they can be managed, both in hospital and as they transition home.
Noninvasive ventilation (NIV) has been a well-established form of ventilatory and oxygenation modality used for many different disease processes. The methods and personnel used to deliver this modality has changed over time. The goal of this webinar is to provide the clinicians with an understanding of the necessary planning and preparations needed to achieve NIV success which includes staff training, equipment selection and tracking.
Noninvasive ventilation, specifically non-invasive positive-pressure ventilation or continuous positive airway pressure delivered by mask, has now become standard care for the management of a number of specific causes of acute respiratory failure. This webinar will focus on a total system approach to achieving optimal use of NIV including device and interface selection, humidification, interface rotation, ventilation, complementary use of HFNT and NIV. This presentation will review the current evidence and best clinical practices available to optimize the use noninvasive ventilation in acute care setting.
Intubation in the emergency department is common and can prevent a patient from dying from a reversible condition. However, it is questionable whether the benefits of intubation outweigh the risks in older patients and whether other modes of ventilatory support would be preferable. . A new study by researchers at Brigham and Women's Hospital investigated the outcomes for patients aged 65 and older after emergency department intubation across a variety of conditions and disease. According to the lead author, one in 3 older patients who underwent intubation in the emergency department died in the hospital. The webinar will address explain the significance of emergency department visit in the overall illness trajectory of seriously ill patients, discuss non-invasive ventilation as an alternative to intubation, and best practices for communications regarding ventilatory support in the elderly patient.
Non-invasive ventilation (NIV) is a widely used and studied therapy option for the management of acute respiratory failure. High flow nasal cannula is rapidly growing in popularity and in supportive evidence. This presentation will review the current evidence in support of NIV, and discuss the current research evaluating HFNC and its role in the management of respiratory
Coughing is an important component of airway clearance, particularly in individuals with pulmonary disease, respiratory muscle weakness, or central nervous system disease that impairs breathing. The use of an in-exsufflation device to promote airway clearance in individuals with neuromuscular disease is essential to avoid retained secretions that cause infection, inflammation, and respiratory failure. This webinar will focus on the basic theory and clinical goals in the application of an in-exsufflation device, patient selection, indications/contraindications, prescription settings and applications in adults versus pediatric populations.
Noninvasive ventilation (NIV) or the delivery of positive pressure ventilation delivered through a noninvasive interface has become more common as its benefits are increasingly recognized. NIV has proven efficacy for hypercapnic respiratory failure, especially that due to COPD exacerbations. High-flow nasal cannula (HFNO) comprises an air/oxygen blender, an active humidifier, a single heated circuit, and a nasal cannula. HFNO has shown promise to treat hypoxic respiratory failure. This webinar will explore a new strategy in the treatment of respiratory conditions. Specifically, this presentation will discuss how HFNO may play a useful complementary role during breaks from NIV.
During the COVID-19 pandemic there has been concern regarding staff exposure from delivering aerosolized medications to patients with the disease. This webinar will provide practical strategies on how to deliver aerosolized medications to patients with COVID-19 safely and effectively. Infection control and prevention in the era of COVID-19 will also be discussed.
Invasive mechanical ventilation is the main supportive therapy used in ICU patients. However, although mechanical ventilation is critical for the survival of patients with acute respiratory failure, it can also be injurious (ventilator-induced lung injury) to non- affected lung areas, or to normal lungs. A well-recognized strategy, lung protective ventilation, can prevent lung injury and decrease morbidity and mortality in ARDS as well as non-ARDS patients. Lung protective ventilation is based on low tidal volumes and limited airway pressures (plateau, PEEP and driving pressures). These parameters need to be closely monitored at bedside in order to develop a personalized approach to protective mechanical ventilation and ultimately, improve outcomes.